Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size


 
Table of Contents   
ORIGINAL ARTICLE
Year : 2011  |  Volume : 6  |  Issue : 3  |  Page : 131-136
Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis


1 Department of Chest Disease, Baskent University Medical and Research Center, Adana, Turkey
2 Baskent University Medical and Research Center, Istanbul, Turkey
3 Baskent University Hospital, Ankara, Turkey

Date of Submission22-Dec-2010
Date of Acceptance07-Mar-2011
Date of Web Publication29-Jun-2011

Correspondence Address:
Mehmet Ali Habesoglu
Department of Chest Disease, Baskent University Adana Teaching and Medical Research Center, Dadaloglu M, 39 S, No 6, YŁregir, 01250 Adana
Turkey
Login to access the Email id


DOI: 10.4103/1817-1737.82443

Rights and Permissions

   Abstract 

Background: Bronchiectasis continues to be one of the major causes of morbidity and mortality in developing countries, with a probably underestimated higher prevalence than in developed countries.
Objective: To assess the clinical profile of adult patients with bronchiectasis.
Methods: We retrospectively reviewed the clinical, radiologic, and physiologic findings of 304 patients with bronchiectasis confirmed by high-resolution computed tomography.
Results: Mean age of participants (45.7% males, 54.3% females) was 56 ± 25 years and 65.8% of them were lifetime non-smokers. Most common identified causes of bronchiectasis were childhood disease (22.7%), tuberculosis (15.5%), and pneumonia (11.5%). The predominant symptoms were productive cough (83.6%), dyspnea (72%), and hemoptysis (21.1%). The most common findings on chest examination were crackles (71.1%) and rhonchi (28.3%). Types of bronchiectasis were cylindrical in 47%, varicose in 9.9%, cystic in 45.1%, and multiple types in 24.3%. Involvement was multilobar in 75.3% and bilateral in 62.5%. Of 274 patients, 20.8% displayed normal pulmonary function test results, whereas 47.4%, 8% and 23.7% showed obstructive, restrictive, and mixed pattern, respectively. Patients with cystic disease had a higher frequency of hemoptysis (42%) and a greater degree of functional impairment, compared to other types.
Conclusion: In patients with bronchiectasis from southern Turkey, generally presenting with recurrent productive cough, hemoptysis, dyspnea, and persistent bibasilar rales, the etiology remains mainly idiopathic. Post-infectious bronchial destruction is one of the major identified underlying pathological processes. The clinical picture and the deterioration of the pulmonary function test might be more severe in patients with cystic type bronchiectasis.


Keywords: Asthma, bronchiectasis, chest X-ray, chronic obstructive pulmonary disease, computed tomography, respiratory function test


How to cite this article:
Habesoglu MA, Ugurlu AO, Eyuboglu FO. Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis. Ann Thorac Med 2011;6:131-6

How to cite this URL:
Habesoglu MA, Ugurlu AO, Eyuboglu FO. Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis. Ann Thorac Med [serial online] 2011 [cited 2019 Oct 17];6:131-6. Available from: http://www.thoracicmedicine.org/text.asp?2011/6/3/131/82443


Bronchiectasis is defined as an irreversible dilatation and destruction of one or more bronchi, with a reduction in clearance of secretions and in the expiratory airflow. This disease can lead to recurrent lower respiratory tract infections, worsening pulmonary functions, respiratory failure and pulmonary hypertension, resulting in deterioration in quality of life, with increased morbidity and premature mortality. [1],[2],[3],[4]

The incidence and prevalance of bronchiectasis are generally not well known and are underestimated in developing countries. [5] Although the prevalence once declined over the past years in societies with high socioeconomic status, probably due to the development of preventive medicine, especially childhood immunizations, and improvement of the living conditions and widespread use of antibiotics, nowadays bronchiectasis has been recognized more, mainly due to the frequent use of high-resolution computerized tomography (HRCT). [6],[7] Compared to developed countries, its prevalence was suggested to be higher in developing countries, especially in patients with less access to healthcare; however, it is probably underestimated [5],[8] when based on healthcare claims or physician-reported cases. In a retrospective analysis, chest computerized tomography findings in health screening examinees revealed a very high prevalence of bronchiectasis (9.1%) in Korean adults, including asymptomatic and mild cases. [8] Bronchiectasis has still been considered as an "orphan" disease because of low clinical suspicion, commercial interest and research activity. [9] As a consequence, scientific concern in non-cystic fibrosis bronchiectasis diminished, with limited literature about this issue compared to other "obstructive lung diseases" and "pneumonia". [10]

The etiology of bronchiectasis varies between different populations. Immune deficiency syndromes, metabolic and ultrastructural defects are the predominant etiologic factors in developed countries, while bacterial and viral infections continue to be major causes of the disease in developing countries. [11] On the other hand, despite using advanced immunological and genetic diagnostic techniques, up to 40% of patients' etiology remains undetermined. [12]

Bronchiectasis seems to be a neglected disorder, with no adequate diagnosis and treatment. In this study, we reviewed the underlying etiologic factors, and the clinical, radiologic, and physiologic findings in 304 patients with bronchiectasis to attract clinician's attention.


   Methods Top


Study subjects and study design

This study was conducted in Baskent University Hospital, Adana, Turkey. The medical records of 483 adult patients (age > 16 years) admitted between 2004 and 2009 with suspicion of bronchiectasis were reviewed retrospectively. The patients were enrolled in the study if the diagnosis was confirmed with HRCT of the thorax. Patients with history of cystic fibrosis, connective tissue disease, interstitial lung disease and radiation therapy were excluded from the study.

Data collection

The demographic data, predisposing factors for bronchiectasis, initial symptoms at admission, duration of symptoms, smoking history and physical examination findings were retrieved from the medical records. The symptoms at presentation were analyzed, even if the diagnosis of bronchiectasis was not evident initially.

Radiologic diagnosis

The plain chest X-rays (CXRs) at the time of diagnosis were reviewed by using the criteria outlined by Gudbjerg [13] for the diagnosis of bronchiectasis; these criteria included the presence of increased pulmonary markings, honeycomb-like structures, atelectasis (loss of lung volume), and pleural changes. A radiologist, unaware of the patients' clinical data, evaluated the HRCT images. The predominant type (i.e. cylindrical, varicose, or cystic according to the Reid classification [14] ) of bronchiectasis was noted.

Spirometry

Pulmonary function testing was done as routine follow-up at outpatient settings. Subjects had spirometry (V max 22; SensorMedics, Yorba Linda, CA, USA) performed for forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC), according to American Thoracic Society guidelines. [15] Patients were divided into four groups on the basis of findings on spirometry. Normal spirometry was defined as FVC and FEV1 greater than 80% predicted as well as FEV1/FVC greater than 70% predicted. Obstructive pattern was defined as the presence of FEV1/FVC less than 70% predicted. Patients with restrictive pattern had FEV1 and FVC values of less than 80% predicted and a preserved FEV/FVC ratio (>70%), whereas patients with mixed disease had FEV1 and FVC values of less than 80% predicted and an FEV/FVC ratio of less than 70%.

Statistical analysis

Statistical analysis was performed using the SPSS package (SPSS Inc., Chicago, IL, USA). Data were expressed as frequency, mean ± standard deviation or median (interquartile range), as appropriate. Clinical and functional features of cystic and non-cystic (cylindrical and varicose) type bronchiectasis were compared. Unpaired Student's t-test was performed for parametric comparisons between two groups, and Mann-Whitney test was applied for nonparametric comparisons between two groups. χ 2 test was used to analyze categorical variables. A P value < 0.05 was considered to be statistically significant.


   Results Top


A total of 483 patients with a diagnosis of bronchiectasis were screened based on ICD-10 coding. Fifty charts (10.3%) could not be reviewed. The diagnosis was inaccurate due to miscoding, or insufficient clinical data were available for 38 (7.8%) of the patients. Five patients were excluded as HRCT was taken during active infection. In 86 (17.8%) of the patients, the diagnosis was not proved by HRCT. The remaining 304 (62.9%) patients were enrolled into the study.

Demographic data and smoking history of the patients are shown in [Table 1]. The mean age of the patients was 56 ± 25 years (range 17-92 years). Patients were mostly in the age range between 50 and 80 years as presented in [Figure 1]. Females were predominant (54.3%). Forty-three out of 104 patients with a history of smoking (14.1%) were current smokers at the time of presentation. Rate of presence of smoking history was 60.4% for males and 12.1% for females (P0 < 0.001).
Table 1: Demographic data of patients

Click here to view
Figure 1: Age distribution in 10-year increments of the 304 patients with bronchiectasis

Click here to view


An underlying etiology was identified in 52.6% of the patients [Table 2]. Most commonly, bronchiectasis was post-infectious (49.7%) due to childhood infections (22.7%), tuberculosis (15.5%) and severe pneumonia (11.5%). There were five patients with immotile cilia syndrome, two patients with immunoglobulin deficiency and two single cases with allergic bronchopulmonary aspergillosis and congenital bronchoesophageal fistula. At the time of assessment, some patients were previously diagnosed with chronic obstructive pulmonary disease (COPD) (18.4%) or asthma (17.8%).
Table 2: Etiology of bronchiectasis

Click here to view


The mean duration of symptoms was 17.4 ± 15.3 years. Cough (83.6%) and sputum (83.6%) were the most frequent complaints [Table 3]. Of 254 patients producing sputum, 139 (54.7%) had daily sputum, whereas 115 (45.3%) produced phlegm significantly during respiratory tract infections. Patients with cystic type bronchiectasis usually complained of daily sputum production, while patients with non-cystic types (cylindrical or varicose types) often complained of significant quantities of sputum only during respiratory tract infections (P < 0.05). Dyspnea was present in approximately two-thirds of the patients. Hemoptysis, mainly as blood streaked, was present in 103 patients; 19 of these were admitted with massive hemoptysis requiring medical treatment (9 patients), bronchial embolization (8 patients) or surgery (2 patients) in the follow-up. Twenty-six of 143 patients (18.2%) with cystic bronchiectasis and 14 of 161 cases (8.6%) with non-cystic (cylindrical or varicose) bronchiectasis had chronic respiratory failure (CRF), receiving long-term oxygen treatment (LTOT); so, it was detected significantly more in the cystic type ( P < 0.05). Nineteen of the patients with CRF had neither COPD nor asthma.
Table 3: Symptoms and sign of bronchiectasis*

Click here to view


As shown in [Table 3], the most common finding of the physical examination was crackles (71.1%); rhonchi (28.3%) and wheezes (21.7%) were the other common examination findings. Only 13 patients had finger clubbing. Crackles as auscultation findings and finger clubbing were more common in cystic type of the disease ( P < 0.05).

Pathological findings were not detected on CXR only in 18 patients. Increased pulmonary marking was the most common radiologic finding (71.1%). These findings are usually described as chronic fibrotic changes. Honeycombing (34.9%), loss of lung volume (30.6%), and pleural abnormalities (8.5%) were the other CXR findings.

According to radiologic examination with HRCT, the predominant type of bronchiectasis was cystic in 143 cases (47%) and non-cystic in 161 cases (53%). More than one type of bronchiectasis was observed in 74 subjects (24.3%).

The radiologic findings of bronchiectasis determined by HRCT were quite extensive as shown in [Table 4]. A median of two lobes (interquartile range 2-3) was involved. A single lobe was affected in 75 cases (24.7%), as with all six lobes in 8 cases (2.6%). It was often distributed to both the lower lobes.
Table 4: Radiologic distribution of bronchiectasis based on HRCT findings*

Click here to view


Spirometric measurements of 274 patients were analyzed [Table 5]. The test was normal in 59 patients (21.5%), obstructive in 128 (46.7%), restrictive in 22 (8%), and mixed in 65 (23.7%) patients. FEV1 and FVC values of patients with cystic type were lower than the values of those with non-cystic type bronchiectasis. Additionally, a mixed pattern was detected more commonly in the cystic group.
Table 5: Pulmonary function test results according to predominant bronchiectasis type of 274 patients

Click here to view



   Discussion Top


In our study with the highest number of adult patients stated in the literature recently, post-infectious bronchial destruction was detected to be the most common reason of non-cystic fibrosis bronchiectasis. The disease was typically characterized by chronic productive cough, dyspnea, bi-basilar crackles and obstructive type spirometric abnormality in our patients. In patients with cystic type bronchiectasis, the clinical picture and the deterioration of the pulmonary function test abnormality were observed to be more severe.

Bronchiectasis is generally not a primary disease, but an anatomical abnormality as a result of many different factors. The primary etiologic factor could not be determined in 30-74% of the patients according to the literature. [16],[17],[18] Similarly, the etiologic factors could be identified in 52.6% of the cases in our study. Pneumonia including tuberculosis infections in younger ages or childhood infections such as measles or pertussis were determined to be the reason of bronchial distortion in most of our patients. In a prospective study searching for the etiology of bronchiectasis, childhood infections were detected in 43% of the cases; however, the disease was attributed primarily to infectious reasons in only 29% of the cases. [18] The bronchial or immunologic abnormalities predisposing to those infections were claimed to be the main reasons in the same study. Because of the retrospective nature of our study, all the underlying anatomic and systemic diseases could not be investigated; therefore, they might be underdetected and understated in this article. In spite of this, our findings support the thesis of infectious agents, preserving their importance in the etiology of bronchiectasis. [16],[17],[18],[19]

Most of our patients were detected to be symptomatic in middle age. They often complained of productive cough and dyspnea at the initial evaluation. While eight cases were admitted because of first-time hemoptysis, there was a history of hemoptysis in approximately one-third of the patients. Hemoptysis was established sometimes as the only reason of assessment and sometimes as a life-threatening complication. In 10 out of 19 cases with massive hemoptysis, bleeding could be controlled by either bronchial artery embolization or surgery.

Chronic respiratory failure is another important complication leading to increased morbidity and worsening of quality of life. In a study of 67 patients with more extended bronchiectasis, admitted to ICU because of acute respiratory failure, 25% of the cases had used LTOT previously. The mortality rate in 1 year was 40% and a previous history of LTOT was identified as a predictor for mortality. [20] In our study including patients with less extended as well as advanced disease, CRF was present in 40 of our patients with the necessity of LTOT at home, and nearly half of them did not have history of COPD or asthma. CRF was observed more in the cystic type of disease.

Bronchiectasis, known as "other obstructive airway disease", [21] may not be always easily differentiated clinically from COPD or asthma. However, in the presence of clinical suspicion, it can be detected and diagnosed by HRCT even in patients with COPD and asthma. It was stated to be present in 29-50% of COPD patients [22],[23] and 9-40% of asthma patients. [24],[25],[26],[27] In this study, COPD and asthma were frequently observed in patients with bronchiectasis. Asthma or COPD were the co-morbidities in 17.8 and 18.4% of our patients, respectively. These rates may give rise to the thought of non-cystic fibrosis bronchiectasis being more prevalent than expected as a co-morbidity to COPD or asthma in our population. Bronchiectasis can unfavorably affect the clinical course of both these diseases by increasing the airway inflammation and bacterial colonization, by increasing the attack severity in COPD, [23] and by contributing to severe and difficult-to-control asthma with pulmonary complications. [27] Therefore, to improve the control of these disorders, bronchiectasis should be considered and investigated as co-morbidity in certain patients.

According to the evaluation of CXR findings, the most common finding was nonspecific chronic fibrotic changes. It was completely normal in 18 cases. In the presence of clinical picture as described above, even though the X-ray findings were normal or nonspecific chronic infiltrations, bronchiectasis should be confirmed with HRCT. On the other hand, a temporary bronchial dilatation and thickening of the bronchial wall named as "pseudo-bronchiectasis" may arise secondary to infection or inflammation at the acute phase. But it becomes permanent when destruction of muscle and elastic tissue in bronchi develops with scarring. Accordingly, it is recommended that HRCT be ordered at least 4 months after an acute infection for diagnosing post-infectious bronchiectasis. [28]

HRCT scanning has been the gold standard diagnostic method in bronchiectasis. [29] The extent and type of the disease can also be determined with HRCT. In nearly half of our patients (47%), cystic type was detected predominantly. It was observed that patients with cystic type had a worse clinical picture than the others, with daily sputum rather than having sputum only during respiratory tract infections, more frequent life-threatening hemoptysis, more significant auscultation findings and more frequent finger clubbing and chronic respiratory failure as a complication. As compared to other types, cystic type bronchiectasis was stated to increase the bacterial colonization in airways (especially Pseudomonas), leading to more significant worsening of pulmonary functions and more frequent development of pulmonary hypertension. [30],[31] Lynch et al . pointed out that type of bronchiectasis might be a predictor of the severity of the disease. [32] Probably, the distortion and inflammation of the airways can be more serious in patients with cystic component, and parallel to this, the clinical picture becomes more severe, as shown in our patients.

Obstructive type spirometric abnormality was detected in most of our patients. Spirometric findings were similar in cylindrical and varicose bronchiectasis, as FEV1 and FVC values were lower in the cystic type than in others. As stated in earlier studies, mixed type pulmonary function abnormality was observed more frequently in the cystic type. [32],[33]

There were some limitations of our study. First, as with any retrospective study, our data were dependent on the availability and accuracy of data in medical records. As such, assessment of rather less frequent predisposing factors, such as immunoglobulinopathies or immotile cilia syndrome, was possible only in some patients, based on the clinical suspicion of the primary evaluating physician. This might have led to overestimation of idiopathic cases, with underestimation of other rare causes. Second, this study is subject to selection bias, since patients were selected from the inpatients of a single tertiary hospital. Therefore, the results might not represent the general population, probably including less severe or asymptomatic cases.

To conclude, our findings state that bronchiectasis might be one of the ongoing important reasons of mortality and morbidity, with worsening quality of life in our region. The disorder is generally presented with recurrent productive cough, hemoptysis, dypnea, and persistent secretory bibasilar rales. It should be considered as co-morbidity in severe and complicated forms of asthma or COPD. Clinicians should be aware of the clinical and radiologic presentation of bronchiectasis for accurate diagnosis and appropriate multimodality treatment.

 
   References Top

1.Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007;132:1565-72.  Back to cited text no. 1
    
2.Alzeer AH, Al-Mobeirek AF, Al-Otair HA, Elzamzamy UA, Joherjy IA, Shaffi AS. Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis. Chest 2008;133:468-73.   Back to cited text no. 2
    
3.King PT, Holdsworth SR, Freezer NJ, Villanueva E, Gallagher M, Holmes PW. Outcome in adult bronchiectasis. COPD 2005;2:27-34.  Back to cited text no. 3
    
4.Alzeer AH, Masood M, Basha SJ, Shaik SA. Survival of bronchiectatic patients with respiratory failure in ICU. BMC Pulm Med 2007;7:17.  Back to cited text no. 4
    
5.Tsang KW, Tipoe GL. Bronchiectasis: Not an orphan disease in the East. Int J Tuberc Lung Dis 2004;8:691-702.  Back to cited text no. 5
    
6.O'Donnel AE. Bronchiectasis. Chest 2008;134:815-23.   Back to cited text no. 6
    
7.Cohen M, Sahn SA. Bronchiectasis in systemic diseases. Chest 1999;116:1063-74.  Back to cited text no. 7
    
8.Kwak HJ, Moon JY, Choi YW, Kim TH, Sohn JW, Yoon HJ, et al. High prevalence of bronchiectasis in adults: Analysis of CT findings in a health screening program. Tohoku J Exp Med 2010;222:237-42.  Back to cited text no. 8
    
9.Barker AF, Bardana EJ Jr. Bronchiectasis: Update of an orphan disease. Am Rev Respir Dis 1988;137:969-78.   Back to cited text no. 9
    
10.Martínez García MA. Bronchiectasis: Still an orphan disease? Arch Bronconeumol 2005;41:407-9.  Back to cited text no. 10
    
11.Cobanoglu U, Yalcinkaya I, Er M, Isik AF, Sayir F, Mergan D. Surgery for bronchiectasis: The effect of morphological types to prognosis. Ann Thorac Med 2011;6:25-32.   Back to cited text no. 11
[PUBMED]  Medknow Journal  
12.Pasteur MC, Bilton D, Hill AT. British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010;65:i1-58.  Back to cited text no. 12
    
13.Gudbjerg CE. Roentgenologic diagnosis of bronchiectasis: An analysis of 112 cases. Acta Radiol 1955;43:210-26.  Back to cited text no. 13
    
14.Swartz MN. Bronchiectasis. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM, editors. Fishman's pulmonary disease and disorders. 3rd ed. New York: McGraw-Hill;1998. p. 2045-70.  Back to cited text no. 14
    
15.Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.  Back to cited text no. 15
    
16.Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995;108:955-61.   Back to cited text no. 16
    
17.King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med 2006;100:2183-9.  Back to cited text no. 17
    
18.Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000;162:1277-84.  Back to cited text no. 18
    
19.Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007;101:1163-70.  Back to cited text no. 19
    
20.Dupont M, Gacouin A, Lena H, Lavoue S, Brinchault G, Delaval P, et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest 2004;125:1815-20.  Back to cited text no. 20
    
21.Mysliwiec V, Pina JS. Bronchiectasis: the 'other' obstructive lung disease. Postgrad Med 1999;106:123-6.   Back to cited text no. 21
    
22.O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55:635-42.  Back to cited text no. 22
    
23.Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, et al. Bronchiectasis, exacerbations indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:400-7.  Back to cited text no. 23
    
24.Harmanci E, Kebapci M, Metintas M, Ozkan R. High-resolution computed tomography findings are correlated with disease severity in asthma. Respiration 2002;69:420-6.  Back to cited text no. 24
    
25.Grenier P, Mourey-Gerosa I, Benali K, Brauner MW, Leung AN, Lenoir S, et al. Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intra-observer variability. Eur Radiol 1996;6:199-206.   Back to cited text no. 25
    
26.Gupta S, Siddiqui S, Haldar P, Raj JV, Entwisle JJ, Wardlaw AJ et al. Qualitative analysis of high-resolution CT scans in severe asthma. Chest 2009;136:1521-8.   Back to cited text no. 26
    
27.Oguzulgen IK, Kervan F, Ozis T, Turktas H. The impact of bronchiectasis in clinical presentation of asthma. South Med J 2007;100:468-71.  Back to cited text no. 27
    
28.Agarwal R. Bronchiectasis in acute pneumonia… pseudobronchiectasis. Chest 2007;132:2054-5.  Back to cited text no. 28
    
29.Webb WR, Muller NL, Naidich DP. Airway diseases. High-resolution CT of the lung. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 467-546.  Back to cited text no. 29
    
30.Angrill J, Agusti C, de Celis R, Filella X, Rañó A, Elena M, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001;164:1628-32.  Back to cited text no. 30
    
31.Alzeer AH. HRCT score in bronchiectasis: Correlation with pulmonary function tests and pulmonary artery pressure. Ann Thorac Med 2008;3:82-6.  Back to cited text no. 31
[PUBMED]  Medknow Journal  
32.Lynch DA, Newell J, Hale V, Dyer D, Corkery K, Fox NL, et al. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. AJR Am J Roentgenol 1999;173:53-8.  Back to cited text no. 32
    
33.Lee JH, Kim YK, Kwang HJ, Chang JH. Relationship between high-resolution computed tomography, lung functionand bacteriology in stable bronchiectasis. J Korean Med Sci 2004;19:62-8.  Back to cited text no. 33
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5]

This article has been cited by
1 Imaging of Cystic Fibrosis and Pediatric Bronchiectasis
Kevin P. Murphy,Michael M. Maher,Owen J. OśConnor
American Journal of Roentgenology. 2016; 206(3): 448
[Pubmed] | [DOI]
2 Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients
Eva Polverino,Catia Cilloniz,Rosario Menendez,Albert Gabarrus,Edmundo Rosales-Mayor,Victoria Alcaraz,Silvia Terraneo,Jordi Puig de la Bella Casa,Josep Mensa,Miquel Ferrer,Antoni Torres
Journal of Infection. 2015; 71(1): 28
[Pubmed] | [DOI]
3 The existence of bronchiectasis predicts worse prognosis in patients with COPD
Bei Mao,Hai-Wen Lu,Man-Hui Li,Li-Chao Fan,Jia-Wei Yang,Xia-Yi Miao,Jin-Fu Xu
Scientific Reports. 2015; 5: 10961
[Pubmed] | [DOI]
4 Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: A prospective study
Qian Qi,Wen Wang,Tao Li,Yan Zhang,Yu Li
Respirology. 2015; 20(6): 917
[Pubmed] | [DOI]
5 result 1 Document Bronchiectasis: Still a problem
Authors of Document Wang, Z.L.
Source of the Document Chinese Medical Journal. 2014;
[Pubmed]
6 Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis
Antonello Nicolini,Federica Cardini,Norma Landucci,Sergio Lanata,Maura Ferrari-Bravo,Cornelius Barlascini
BMC Pulmonary Medicine. 2013; 13(1): 21
[Pubmed] | [DOI]
7 Alpha 1 antitrypsin deficiency in non cystic fibrosis bronchiectasis
Mohamed Shahat Badawy,Atef Farouk El Qarn,Hamdy Ali Mohamadeen
Egyptian Journal of Chest Diseases and Tuberculosis. 2013; 62(2): 311
[Pubmed] | [DOI]
8 Azithromycin in bronchiectasis: When should it be used?
Wilson, R. and Wells, A.U.
The Lancet. 2012; 380(9842): 627-629
[Pubmed]
9 Mounier-Kuhn syndrome: The role of bronchiectasis in clinical presentation
Marchiori, E., Sousa, A.S., Zanetti, G., Hochhegger, B.
Annals of Thoracic Medicine. 2012; 7(1): 51
[Pubmed]
10 Azithromycin in bronchiectasis: when should it be used?
Robert Wilson,Athol U Wells
The Lancet. 2012; 380(9842): 627
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (498 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    Methods
    Results
    Discussion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed5981    
    Printed227    
    Emailed4    
    PDF Downloaded891    
    Comments [Add]    
    Cited by others 10    

Recommend this journal